Remdesivir Progresses on Coronavirus Trial: Pharma Upbeat

by Ritujay Ghosh Published on April 30,2020

A large number of biotech companies have been working on developing drugs and vaccine for the novel coronavirus that has infected more than 3,100,000 and claimed 227,000 lives.

• REGN Quick QuoteREGNNegative Net Change
• SNY Quick QuoteSNYNegative Net Change
• PFE Quick QuotePFEPositive Net Change
• GILD Quick QuoteGILDNegative Net Change
• MRNA Quick QuoteMRNANegative Net Change
• LLY Quick QuoteLLYPositive Net Change
• GSK Quick QuoteGSKNegative Net Change
• AMGN Quick QuoteAMGNPositive Net Change
• ADPT Quick QuoteADPTNegative Net Change
• BNTX Quick QuoteBNTXNegative Net Change

• biotechs
• medical

Healthcare ETFs to Gain on Progress in Coronavirus Vaccine

by Sweta Jaiswal, FRM Published on April 29,2020

The healthcare space is heated up with players rushing to come up with a vaccine for COVID-19.

• JNJ Quick QuoteJNJPositive Net Change
• SNY Quick QuoteSNYNegative Net Change
• PFE Quick QuotePFEPositive Net Change
• MRNA Quick QuoteMRNANegative Net Change
• GSK Quick QuoteGSKNegative Net Change
• IBB Quick QuoteIBBNegative Net Change
• XLV Quick QuoteXLVNegative Net Change
• VHT Quick QuoteVHTNegative Net Change
• XBI Quick QuoteXBINegative Net Change
• BBH Quick QuoteBBHPositive Net Change

• biotechs
• etfs

Is a Beat in Store for Amarin (AMRN) This Earnings Season?

by Zacks Equity Research Published on April 29,2020

Amarin's (AMRN) first-quarter results are likely to reflect strong demand for its cardiovascular drug, Vascepa.

• SNY Quick QuoteSNYNegative Net Change
• AMGN Quick QuoteAMGNPositive Net Change
• AMRN Quick QuoteAMRNPositive Net Change
• ALLO Quick QuoteALLONegative Net Change

• pharmaceuticals

AstraZeneca (AZN) Q1 Earnings & Sales Beat, Increase Y/Y

by Zacks Equity Research Published on April 29,2020

AstraZeneca (AZN) beats estimates for both earnings and sales. It maintains its financial outlook for the year.

• SNY Quick QuoteSNYNegative Net Change
• AZN Quick QuoteAZNNegative Net Change
• PFE Quick QuotePFEPositive Net Change
• MRK Quick QuoteMRKPositive Net Change

• pharmaceuticals

The Zacks Analyst Blog Highlights: Moderna, Johnson & Johnson, Sanofi and Novavax

by Zacks Equity Research Published on April 29,2020

The Zacks Analyst Blog Highlights: Moderna, Johnson & Johnson, Sanofi and Novavax

• JNJ Quick QuoteJNJPositive Net Change
• SNY Quick QuoteSNYNegative Net Change
• MRNA Quick QuoteMRNANegative Net Change
• NVAX Quick QuoteNVAXPositive Net Change

• medical

Should Value Investors Buy Sanofi (SNY) Stock?

by Zacks Equity Research Published on April 28,2020

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

• SNY Quick QuoteSNYNegative Net Change

• cheap-stocks
• pe-ratio
• undervalued-stocks
• valuation
• value-stocks

3 Stocks to Benefit From Race to Develop Coronavirus Vaccines

by Zacks Equity Research Published on April 28,2020

Pharmaceutical companies and scientists are relentlessly working on developing coronavirus vaccines and the progress in trails has helped stocks to rally.

• JNJ Quick QuoteJNJPositive Net Change
• SNY Quick QuoteSNYNegative Net Change
• MRNA Quick QuoteMRNANegative Net Change
• NVAX Quick QuoteNVAXPositive Net Change

• biotechs
• medical
• pharmaceuticals

Novavax (NVAX) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research Published on April 27,2020

During Novavax's (NVAX) upcoming Q1 earnings call, investor focus will be on the company's progress with its seasonal influenza vaccine candidate, NanoFlu, and the COVID-19 vaccine candidate.

• ALXN Quick QuoteALXNPositive Net Change
• SNY Quick QuoteSNYNegative Net Change
• NVAX Quick QuoteNVAXPositive Net Change
• EXAS Quick QuoteEXASNegative Net Change

• biotechs

Big Drug Stock Q1 Earnings Due on Apr 28: MRK, PFE and NVS

by Kinjel Shah Published on April 27,2020

Let us take a look at three big drug companies due to release their first-quarter financial results on Apr 28.

• JNJ Quick QuoteJNJPositive Net Change
• SNY Quick QuoteSNYNegative Net Change
• PFE Quick QuotePFEPositive Net Change
• MRK Quick QuoteMRKPositive Net Change
• LLY Quick QuoteLLYPositive Net Change
• NVS Quick QuoteNVSNegative Net Change

• pharmaceuticals

Company News for Apr 27, 2020

by Zacks Equity Research Published on April 27,2020

Companies In The News Are: VZ, AXP, FCX, SNY.

• VZ Quick QuoteVZPositive Net Change
• SNY Quick QuoteSNYNegative Net Change
• AXP Quick QuoteAXPNegative Net Change
• FCX Quick QuoteFCXNegative Net Change

• basic-materials
• communications
• finance
• pharmaceuticals

Sanofi (SNY) Q1 Earnings, Sales Grow on Coronavirus-Led Buying

by Zacks Equity Research Published on April 24,2020

Sanofi (SNY) beats estimates for both earnings and sales. Around half of the sales and earnings growth at CER was due to COVID-19 associated patient stockpiling. Stock down.

• REGN Quick QuoteREGNNegative Net Change
• SNY Quick QuoteSNYNegative Net Change
• GSK Quick QuoteGSKNegative Net Change
• TBIO Quick QuoteTBIOPositive Net Change

• pharmaceuticals

Pfizer/BioNTech to Begin Coronavirus Vaccine Study in Germany

by Zacks Equity Research Published on April 23,2020

Pfizer (PFE) and BioNTech receive approval from regulatory authority in Germany to start an early-stage clinical study to evaluate their mRNA-based vaccine candidates for COVID-19.

• SNY Quick QuoteSNYNegative Net Change
• PFE Quick QuotePFEPositive Net Change
• MRNA Quick QuoteMRNANegative Net Change
• BNTX Quick QuoteBNTXNegative Net Change

• pharmaceuticals

Sanofi (SNY) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research Published on April 22,2020

Investor focus is likely to be on the impact of the coronavirus outbreak on Sanofi's (SNY) performance when it reports first-quarter results.

• REGN Quick QuoteREGNNegative Net Change
• SNY Quick QuoteSNYNegative Net Change
• LLY Quick QuoteLLYPositive Net Change
• GSK Quick QuoteGSKNegative Net Change

• pharmaceuticals

Biotech ETFs Gaining on Progress in Coronavirus Treatment

by Sweta Jaiswal, FRM Published on April 21,2020

The race to introduce vaccine and treatment for coronavirus is opening up opportunities, making the biotech sector a prospective space for investments.

• REGN Quick QuoteREGNNegative Net Change
• SNY Quick QuoteSNYNegative Net Change
• RHHBY Quick QuoteRHHBYPositive Net Change
• GILD Quick QuoteGILDNegative Net Change
• INCY Quick QuoteINCYNegative Net Change
• NVS Quick QuoteNVSNegative Net Change
• AMGN Quick QuoteAMGNPositive Net Change
• ATHX Quick QuoteATHXPositive Net Change
• PSTI Quick QuotePSTIPositive Net Change
• IBB Quick QuoteIBBNegative Net Change
• ADPT Quick QuoteADPTNegative Net Change
• MESO Quick QuoteMESOPositive Net Change
• XBI Quick QuoteXBINegative Net Change
• BB Quick QuoteBBNegative Net Change

• biotechs
• etfs

Karyopharm Starts Dosing With Selinexor for Coronavirus Infection

by Zacks Equity Research Published on April 21,2020

Karyopharm (KPTI) doses the first patient in a phase II study evaluating the low dose of its drug Xpovio (selinexor) to treat hospitalized patients with severe COVID-19 infection. Shares up.

• SNY Quick QuoteSNYNegative Net Change
• RHHBY Quick QuoteRHHBYPositive Net Change
• KPTI Quick QuoteKPTINegative Net Change
• BHC Quick QuoteBHCPositive Net Change

RedHill's Oncology Candidate to be Tested for Coronavirus

by Zacks Equity Research Published on April 21,2020

RedHill (RDHL) inks a deal with NIAID for non-clinical testing of its investigational candidate RHB-107 to evaluate its activity against COVID-19. Stock up.

• BCRX Quick QuoteBCRXNo Net Change
• SNY Quick QuoteSNYNegative Net Change
• RHHBY Quick QuoteRHHBYPositive Net Change
• RDHL Quick QuoteRDHLNegative Net Change

• medical

A Q1 Earnings Primer: Global Week Ahead

by John Blank Published on April 20,2020

The coming wave of Q1 earnings releases will be parsed for fresher signals of economic activity -- including forward guidance -- than tends to be available from conventional macro releases.

• VZ Quick QuoteVZPositive Net Change
• LUV Quick QuoteLUVPositive Net Change
• INTC Quick QuoteINTCPositive Net Change
• SNY Quick QuoteSNYNegative Net Change
• ASML Quick QuoteASMLPositive Net Change
• STM Quick QuoteSTMPositive Net Change
• KGC Quick QuoteKGCNegative Net Change
• DAL Quick QuoteDALPositive Net Change
• LMT Quick QuoteLMTNegative Net Change
• CS Quick QuoteCSNegative Net Change
• KO Quick QuoteKONegative Net Change
• NFLX Quick QuoteNFLXPositive Net Change
• ALPMY Quick QuoteALPMYNegative Net Change
• HII Quick QuoteHIINegative Net Change
• VLVLY Quick QuoteVLVLYPositive Net Change

• earnings

The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Moderna, Sanofi, Vaxart and Eli Lilly

by Zacks Equity Research Published on April 20,2020

The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Moderna, Sanofi, Vaxart and Eli Lilly

• REGN Quick QuoteREGNNegative Net Change
• SNY Quick QuoteSNYNegative Net Change
• MRNA Quick QuoteMRNANegative Net Change
• LLY Quick QuoteLLYPositive Net Change
• VXRT Quick QuoteVXRTPositive Net Change

• medical

Gilead Increases Enrollment Target, Pharma Rally Continues

by Ritujay Ghosh Published on April 20,2020

Substantial progress has been made over the past few weeks with pharmaceutical companies speeding up development of coronavirus vaccines.

• SNY Quick QuoteSNYNegative Net Change
• DVAX Quick QuoteDVAXNegative Net Change
• GILD Quick QuoteGILDNegative Net Change
• MRNA Quick QuoteMRNANegative Net Change
• GSK Quick QuoteGSKNegative Net Change
• AMGN Quick QuoteAMGNPositive Net Change
• ADPT Quick QuoteADPTNegative Net Change

• biotechs
• medical
• pharmaceuticals

5 Best Leveraged ETF Areas of Last Week

by Sanghamitra Saha Published on April 20,2020

If investors can identify the trending investing area amid all the coronavirus chaos, they can easily take a leveraged position on that and beat the broader market.

• JNJ Quick QuoteJNJPositive Net Change
• NVDA Quick QuoteNVDAPositive Net Change
• SNY Quick QuoteSNYNegative Net Change
• PFE Quick QuotePFEPositive Net Change
• GILD Quick QuoteGILDNegative Net Change
• ABT Quick QuoteABTNegative Net Change
• TSM Quick QuoteTSMPositive Net Change
• LABU Quick QuoteLABUNegative Net Change
• SOXL Quick QuoteSOXLPositive Net Change
• CURE Quick QuoteCURENegative Net Change
• WANT Quick QuoteWANTNo Net Change
• NEED Quick QuoteNEEDPositive Net Change
• FNGU Quick QuoteFNGUPositive Net Change
• FNGO Quick QuoteFNGOPositive Net Change

• etfs

Roche's New Test to Detect Antibodies to Fight Coronavirus

by Zacks Equity Research Published on April 17,2020

Roche (RHHBY) develops Elecsys, a new serology test, for the detection of antibodies against SARS-CoV-2, the virus causing COVID-19. The company plans to launch the same early next month.

• REGN Quick QuoteREGNNegative Net Change
• SNY Quick QuoteSNYNegative Net Change
• RHHBY Quick QuoteRHHBYPositive Net Change
• INCY Quick QuoteINCYNegative Net Change

• pharmaceuticals

Sanofi/Luminostics to Make Self-Testing Solution for Coronavirus

by Zacks Equity Research Published on April 17,2020

Sanofi (SNY) partners with Luminostics to make a COVID-19 smartphone-based self-testing solution, which will be based on the latter's proprietary technology.

• REGN Quick QuoteREGNNegative Net Change
• SNY Quick QuoteSNYNegative Net Change
• GSK Quick QuoteGSKNegative Net Change
• TBIO Quick QuoteTBIOPositive Net Change

• pharmaceuticals

Moderna Rallies on US Government Grant for Coronavirus Vaccine

by Zacks Equity Research Published on April 17,2020

Moderna (MRNA) gets a commitment of up to $483 million from the U.S. Government Agency BARDA to accelerate the development of its mRNA-based coronavirus vaccine.

• SNY Quick QuoteSNYNegative Net Change
• MRNA Quick QuoteMRNANegative Net Change
• GSK Quick QuoteGSKNegative Net Change
• TBIO Quick QuoteTBIOPositive Net Change

• biotechs

Pharma Stock Roundup: JNJ's Q1 Earnings, Coronavirus Product Development Efforts

by Kinjel Shah Published on April 17,2020

J&J (JNJ) announces Q1 results. Several companies offer update on their studies/plans to make coronavirus treatments or vaccines

• JNJ Quick QuoteJNJPositive Net Change
• SNY Quick QuoteSNYNegative Net Change
• AZN Quick QuoteAZNNegative Net Change
• PFE Quick QuotePFEPositive Net Change
• MRK Quick QuoteMRKPositive Net Change
• LLY Quick QuoteLLYPositive Net Change
• GSK Quick QuoteGSKNegative Net Change

• pharmaceuticals

Can Contact-Tracing Apps Bring the Lockdown to a Close?

by Manaswita Ghosh Dutta Published on April 17,2020

Major tech giants join forces to introduce mobile contact-tracing applications in a bid to resume normalcy in life amid the pandemic.

• SNY Quick QuoteSNYNegative Net Change
• AAPL Quick QuoteAAPLNegative Net Change
• GOOGL Quick QuoteGOOGLPositive Net Change

• computers
• medical